Ad hoc:

(Thomson Reuters ONE) -
Carl Zeiss Meditec AG /
Dividend /
Ad hoc:
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Resolution of the Supervisory Board: Planned dividend increase to ? 0.40

Jena, 29 November 2012 At its meeting today to adopt the financial statements,
at 11:40 a.m., the Supervisory Board of Carl Zeiss Meditec AG (ISIN:
DE0005313704) agreed to the Management Board's recommendation to propose to the
Annual General Meeting on 5 March 2013 the payment of a regular dividend for
financial year 2011/2012 of ? 0.40 per no-par value share (previous year:
? 0.30). This would increase the total dividend by 33.3% compared with the
previous year, to ? 32.5 million. The dividend ratio as a share of consolidated
net income after non-controlling interests would be 45.3%.

In the past financial year the revenue of the Carl Zeiss Meditec Group increased
by 13.6% (adjusted for currency effects: 9.4%), to ? 861.9 million (previous
year: ? 758.8 million).

The Group's earnings before interest and taxes (EBIT) rose by 18.7% to ? 122.9
million (previous year: ? 103.6 million); the EBIT margin improved to 14.3%
(previous year: 13.6%). Consolidated net income after non-controlling interests
amounts to ? 71.9 million (previous year: ? 66.9 million). Earnings per share
thus increased to ? 0.88 (previous year: ? 0.82).

These results shall be presented in detail at the planned analysts' conference
on 6 December 2012 in Frankfurt am Main.

Investor Relations contact
Henriette Meyer, Director Investor Relations, Carl Zeiss Meditec AG
Phone +49 (0)3641 220-106, E-Mail: investors(at)meditec.zeiss.com

Press contact
Jann Gerrit Ohlendorf, Director Corporate Communications, Carl Zeiss Meditec
AG Phone+49 (0)3641 220-331, E-Mail: press(at)meditec.zeiss.com

This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Carl Zeiss Meditec AG via Thomson Reuters ONE
[HUG#1661392]

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 29.11.2012 - 12:28 Uhr
Sprache: Deutsch
News-ID 208157
Anzahl Zeichen: 2582

contact information:
Town:

Jena

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 128 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ad hoc:"
steht unter der journalistisch-redaktionellen Verantwortung von

Carl Zeiss Meditec AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Inventor of ENT surgical microscopes heralds digital age in visualization ...

TIVATO 700 and EXTARO 300 from ZEISS launch emerging workflow-enhancing augmentation concepts to ENT. At this year?s AAO-HNSF Annual Meeting in Atlanta, USA, the ZEISS Medical Technology business segment presents its revolutionizing solutions for ENT ...

ZEISS removes barriers for Minimally Invasive Spine Surgery ...

At this year?s NASS Annual Meeting in Los Angeles, USA, the ZEISS Medical Technology business segment introduces an innovative visualization system ? TIVATO? 700 from ZEISS ? to the spine community. ?When developing the ZEISS TIVATO 700 we involved e ...

Expanded functionalities of Robotic Visualization System ZEISS KINEVO 900 now av ...

At this year's meeting of the Congress of Neurological Surgeons (CNS) in Boston, Massachusetts, ZEISS Medical Technology is offering additional functionalities of ZEISS KINEVO 900 to customers in the USA after they have been granted regulatory F ...

Alle Meldungen von Carl Zeiss Meditec AG